SurGenTec Launches TiLink Posterior Sacroiliac Fusion

SurGenTec TiLink SI Fusion

SurGenTec received FDA clearance to market TiLink-P, a minimally invasive implant for the treatment of chronic sacroiliac (SI) joint pain.

TiLink-P combines compression across the sacroiliac joint with a posterior implantation approach, offering physicians the ability to stabilize the region. This minimally invasive technology requires one...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us